Samantha Aguilar, PharmD, BCIDP, AAHIVP
banner
samaureus.bsky.social
Samantha Aguilar, PharmD, BCIDP, AAHIVP
@samaureus.bsky.social
Microbiologist ➡️ ID Pharmacist 🧫🦠💊
ID PharmD @ some nice gig
PGY1 & PGY2 ID at University Health in SA,TX
🎓UT Austin COP🤘🏽🧡| CLS at UTHSCSA
Patient Advocate for all
Proud Latina Immigrant
Dog mom, big geek, music enthusiast
Apply to our PGY1 Pharmacy Residency Program at Ochsner LSU Health Shreveport!

💊 Learn more about our program: lnkd.in/eftPgv36 💊

#PharmacyResidency #PGY1 #OchsnerLSUHealth #PhORCAS #ClinicalPharmacy #ASHP #PharmacyLeadership #ResidencyRecruitment
November 6, 2025 at 5:22 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
The updated SOFA-2 scores was released today!

It updates original SOFA score with more contemporary practices.

#IDSky

jamanetwork.com/journals/jam...
October 30, 2025 at 12:46 AM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
There is still a widespread belief that fever is harmful and that it should be
treated regardless of the underlying cause, which is not supported by clinical data.
🆕💫 Review: Fever in sepsis revisited: Is a little heat what we need? #idsky
academic.oup.com/ofid/article...
October 1, 2025 at 7:35 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
When we care for PWH who have virologic suppression, but possible or confirmed NRTI resistance, can we switch them to a simple oral treatment -- once-daily BIC/FTC/TAF? This study says yes, with results strengthened by proviral DNA testing. #IDSky #HIVSky www.sciencedirect.com/science/arti...
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti:...
Patients on second-line protease inhibitor-based regimens in low-income and middle-income countries have high rates of nucleoside reverse transcriptas…
www.sciencedirect.com
August 28, 2025 at 12:07 AM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
August 27, 2025 at 1:21 AM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
🏭 Manufacturers work with CLSI & FDA to stay aligned and update breakpoints efficiently.
🎙️ Hear Andrea Prinzi break it down on Let’s Talk Micro — brought to you by bioMérieux.
👉 Listen: asm.org/podcasts/let...

#AST #Breakpoints #Microbiology #LetsTalkMicro #bioMérieux
August 26, 2025 at 1:47 AM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia

✅ Just Accepted
⭐ Editor's Choice
#IDSky
Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia
Stenotrophomonas maltophilia, a multidrug-resistant nosocomial pathogen, is associated with high mortality and therapeutic challenges...
doi.org
August 13, 2025 at 10:30 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Finally published
🆕🔥DOTS RCT
Among participants with complicated S aureus bacteremia who achieved blood culture clearance, dalbavancin was not superior to standard therapy for achieving a more desirable outcome at day 70 #idsky
jamanetwork.com/journals/jam...
August 13, 2025 at 3:07 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
DOTS trial is published!

It will be interesting to see how data correlates with SNAP.

jamanetwork.com/journals/jam...

Thanks to @jonathanrydermd.bsky.social and @kenkoonwong.bsky.social for letting me know!

#IDSky
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia
This clinical trial compares the efficacy and safety of dalbavancin vs standard therapy for completion of treatment of complicated Staphylococcus aureus bacteremia in hospitalized patients.
jamanetwork.com
August 13, 2025 at 8:27 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

✅ Just Accepted
⭐ Editor's Choice
#IDSky
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US
CAB/RPV for people with HIV and persistent viremia in the US would lead to more viral suppression and fewer deaths compared to oral-based ART regimens. Inc
doi.org
August 13, 2025 at 11:54 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia

✅ Just Accepted
⭐ Editor's Choice
#IDSky
Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia
Stenotrophomonas maltophilia, a multidrug-resistant nosocomial pathogen, is associated with high mortality and therapeutic challenges due to resistance.
academic.oup.com
August 11, 2025 at 9:11 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
⭐️ 📄 ⭐️

Recently @pharmermeg.bsky.social updated this open-access post. Originally published in 2017, the new version has a complete overhaul & provides a downloadable document. This is an article that has been read by by tens thousands of people 🌎🌍🌏.

www.idstewardship.com/cross-reacti... #IDsky
August 8, 2025 at 9:48 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
I know RFK Jr. has assembled a quack crew to concoct a study showing otherwise but here is an new important large cohort study of over 1.2 million children in Denmark showing no association Aluminum adsorbed vaccines and chronic dz in childhood including autism.
www.acpjournals.org/doi/10.7326/...
July 14, 2025 at 11:14 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Taxonomy shift 🚨
Candida auris has been reclassified as Candidozyma auris (C auris ) to reflect its distinct genetic profile from other Candida species. #IDSky #microsky
July 10, 2025 at 2:06 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Bactericidal vs Bacteriostatic Antibiotics. This controversial topic has important conceptual ramifications to treat severe infections. youtu.be/3z4BItBrzbk
Bactericidal vs Bacteriostatic Antibiotics - Editors in Conversation Podcast, Live from ASM Microbe
YouTube video by American Society for Microbiology
youtu.be
July 9, 2025 at 6:47 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
1/ The first #ACIP meeting with RFK Jr.’s handpicked members wrapped up yesterday. Over 4,000 tuned in—a level of attention we haven’t seen since the pandemic. And for good reason: these meetings shape vaccine policy, coverage, timing, access and availability. Here's what happened 👇
June 27, 2025 at 2:22 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
RFK Jr.‘s extreme anti-vax views — and his related conflicts of interest — were a huge problem during his confirmation process.

So he promised not to change the vaccine advisory panel.

Today, he fired every single expert on that panel. It's a public health disaster.
RFK Jr. ousts entire CDC vaccine advisory committee
Health Secretary Robert F. Kennedy Jr. has removed every member of a scientific committee that advises the Centers for Disease Control and Prevention on how to use vaccines.
apnews.com
June 9, 2025 at 10:34 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Today more than ever I think it is important to remind ourselves that #ElonMusk led indiscriminate cuts which have resulted in the estimated deaths of over 300,000 people globally to date. 2/3rds of these are children!!!
He is still very much a villain.
www.impactcounter.com/dashboard?vi...
June 5, 2025 at 10:32 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Um. 🤔Who could have known these citations were fake…🤷‍♀️

Kennedy R. Brain worms: Unlocking creativity and spontaneous bad ideas. Inst Fake Neurol 2024;42(3):123-124.

Prasad M. COVID-19: Panic shopping and other pandemic benefits. Pandemics J. 2023;15(2):45-46.

www.rollingstone.com/politics/pol...
RFK Jr.'s MAHA Report Cites Research Studies That Don't Exist
Health and Human Services Secretary Robert F. Kennedy Jr.'s MAHA Report featured several seemingly fake studies and incorrect attributions.
www.rollingstone.com
May 29, 2025 at 9:38 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated with Prolonged Durations

✅ Just Accepted
⭐ Editor's Choice
#IDSky
Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated with Prolonged Durations
In this study of 4,240 GN-BSI episodes during 2019 from 24 U.S. hospitals, the median duration of therapy was 12 days (IQR 9-15); 59% were treated for >10 days. There was marked variability in treatment durations across hospitals.
doi.org
May 24, 2025 at 2:33 PM
Happy infectious diseases pharmacist day 💊🧫🦠 love being able to advocate for AMS, ID DDI, and optimize cost effective therapy for our patients and institution! #IDPharmacistsDay #SIDPAdvocacy #FutureOfIDPharmacy #PharmacistsLeadingChange @sidpharm.bsky.social
May 22, 2025 at 4:08 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
Improved Detection of HIV-1 Drug Resistance with Droplet Digital PCR: A Comparative Study and Its Implications

✅ Just Accepted
#IDSky
Improved Detection of HIV-1 Drug Resistance with Droplet Digital PCR: A Comparative Study and Its Implications
HIV drug resistance (HIVDR) is a crucial factor in treatment failure. Sanger sequencing, the current gold standard for resistance testing, cannot detect low-abundance variants constituting less than 20% of the virus population.
doi.org
May 18, 2025 at 9:11 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
May 18, 2025 at 10:40 AM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
“Our study demonstrated associations between obesity, particularly severe obesity, and the incidence of 16 common health outcomes.” 📋 Read the full study results by Z. Yao et al. in NEJM Evidence: eviden.cc/4iIRjGg

#MedSky #EndoSky
May 11, 2025 at 1:01 PM
Reposted by Samantha Aguilar, PharmD, BCIDP, AAHIVP
wow...and sad.
Just passing along some friendly advice on how to approach potential changes to the Australian health care system @drruthmitchell.bsky.social
May 5, 2025 at 4:17 AM